226 related articles for article (PubMed ID: 36293314)
21. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
Gupta V; Datta P
Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
[TBL] [Abstract][Full Text] [Related]
22. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
MacNair CR; Brown ED
mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
Wright GD
Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
[TBL] [Abstract][Full Text] [Related]
24. The use of 4-Hexylresorcinol as antibiotic adjuvant.
Nikolaev YA; Tutel'yan AV; Loiko NG; Buck J; Sidorenko SV; Lazareva I; Gostev V; Manzen'yuk OY; Shemyakin IG; Abramovich RA; Huwyler J; El'-Registan GI
PLoS One; 2020; 15(9):e0239147. PubMed ID: 32960928
[TBL] [Abstract][Full Text] [Related]
25. Nonlethal Molecular Nanomachines Potentiate Antibiotic Activity Against Gram-Negative Bacteria by Increasing Cell Permeability and Attenuating Efflux.
Santos AL; Liu D; van Venrooy A; Beckham JL; Oliver A; Tegos GP; Tour JM
ACS Nano; 2024 Jan; 18(4):3023-3042. PubMed ID: 38241477
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic Adjuvants: Make Antibiotics Great Again!
Douafer H; Andrieu V; Phanstiel O; Brunel JM
J Med Chem; 2019 Oct; 62(19):8665-8681. PubMed ID: 31063379
[TBL] [Abstract][Full Text] [Related]
27. Overcoming intrinsic resistance in gram-negative bacteria using small molecule adjuvants.
Melander RJ; Mattingly AE; Nemeth AM; Melander C
Bioorg Med Chem Lett; 2023 Jan; 80():129113. PubMed ID: 36566797
[TBL] [Abstract][Full Text] [Related]
28. Repurposing primaquine as a polyamine conjugate to become an antibiotic adjuvant.
Pearce AN; Chen D; Edmeades LR; Cadelis MM; Troudi A; Brunel JM; Bourguet-Kondracki ML; Copp BR
Bioorg Med Chem; 2021 May; 38():116110. PubMed ID: 33831695
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antibacterial activity of derivatives of 6-O-allylic acylides.
Xu P; Liu L; Jin Z; Lei P
Bioorg Med Chem Lett; 2007 Jun; 17(12):3330-4. PubMed ID: 17459704
[TBL] [Abstract][Full Text] [Related]
30. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
31. Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria.
Barker WT; Nemeth AM; Brackett SM; Basak AK; Chandler CE; Jania LA; Zuercher WJ; Melander RJ; Koller BH; Ernst RK; Melander C
ACS Infect Dis; 2019 Oct; 5(10):1764-1771. PubMed ID: 31434474
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.
Lubell Y; Turner P; Ashley EA; White NJ
Trop Med Int Health; 2011 Oct; 16(10):1192-205. PubMed ID: 21740488
[TBL] [Abstract][Full Text] [Related]
33. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
[TBL] [Abstract][Full Text] [Related]
34. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
Bernier SP; Son S; Surette MG
J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
[TBL] [Abstract][Full Text] [Related]
35. Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii.
Marrujo SA; Hubble VB; Yang J; Wang M; Nemeth AM; Barlock SL; Juarez D; Smith RD; Melander RJ; Ernst RK; Chang M; Melander C
Eur J Med Chem; 2023 May; 253():115329. PubMed ID: 37023677
[TBL] [Abstract][Full Text] [Related]
36. Motuporamine Derivatives as Antimicrobial Agents and Antibiotic Enhancers against Resistant Gram-Negative Bacteria.
Borselli D; Blanchet M; Bolla JM; Muth A; Skruber K; Phanstiel O; Brunel JM
Chembiochem; 2017 Feb; 18(3):276-283. PubMed ID: 28098416
[TBL] [Abstract][Full Text] [Related]
37. Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria.
Yu Y; Zhao H; Lin J; Li Z; Tian G; Yang YY; Yuan P; Ding X
Int J Antimicrob Agents; 2022 May; 59(5):106582. PubMed ID: 35378227
[TBL] [Abstract][Full Text] [Related]
38. Membrane-Active Metallopolymers: Repurposing and Rehabilitating Antibiotics to Gram-Negative Superbugs.
Hwang J; Barman S; Gao R; Yang X; O'Malley A; Nagarkatti P; Nagarkatti M; Chruszcz M; Tang C
Adv Healthc Mater; 2023 Dec; 12(31):e2301764. PubMed ID: 37565371
[TBL] [Abstract][Full Text] [Related]
39. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
[TBL] [Abstract][Full Text] [Related]
40. Repurposing the Hedgehog pathway inhibitor, BMS-833923, as a phosphatidylglycerol-selective membrane-disruptive colistin adjuvant against ESKAPE pathogens.
Zhang N; Shan W; Gao L; Kou SH; Lu C; Yang H; Peng B; Tam KY; Lee LTO; Zheng J
Int J Antimicrob Agents; 2023 Sep; 62(3):106888. PubMed ID: 37328075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
